<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75641">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02026544</url>
  </required_header>
  <id_info>
    <org_study_id>PRO-0001</org_study_id>
    <nct_id>NCT02026544</nct_id>
  </id_info>
  <brief_title>Effect of Low Frequency Ultrasound on Kidney Function</brief_title>
  <official_title>Evaluation of the Effect of Low Frequency Therapeutic Ultrasound (LOTUS) on Kidney Function in Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sonogenix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sonogenix</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out what effect, if any, Low Frequency Therapeutic
      Ultrasound (LOTUS) has on kidney function in patients with chronic kidney disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Glomerular Filtration Rate (GFR)</measure>
    <time_frame>Baseline and 15 minutes after start of Intervention</time_frame>
    <safety_issue>No</safety_issue>
    <description>Absolute change in glomerular filtration rate, GFR, measured by Tc-99m DTPA (diethylenetriamine pentaacetic acid) imaging (Gates Method) in the treated kidney(s) from baseline to during LOTUS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent change in GFR</measure>
    <time_frame>Baseline and 15 minutes after start of Intervention</time_frame>
    <safety_issue>No</safety_issue>
    <description>Percent change in GFR in the treated kidney(s) from baseline to during LOTUS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Baseline and 15 minutes after start of Intervention, and 5 minutes after end of intervention</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood pressure is measured at baseline, during LOTUS intervention, and immediately after LOTUS intervention</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cutaneous Injury</measure>
    <time_frame>5 minutes after LOTUS intervention</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Occurrence of cutaneous injury, such as erythema, blistering or rash occuring below the site of transducer placement</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart rate</measure>
    <time_frame>Baseline and 15 minutes after start of Intervention, and 5 minutes after end of intervention.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Heart rate will be measured at baseline, during LOTUS intervention, and immediately after LOTUS intervention has ended.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Low Frequency Therapeutic Ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low Frequency Therapeutic Ultrasound (LOTUS) applied transcutaneously</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low Frequency Therapeutic Ultrasound</intervention_name>
    <description>29 kHz (kilohertz) low frequency therapeutic ultrasound delivered transcutaneously</description>
    <arm_group_label>Low Frequency Therapeutic Ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be &gt;/= 18 years of age

          -  Must have documented Stage 3 to Stage 4 (eGFR 15 - 59) chronic kidney disease

          -  Females with childbearing potential must not be pregnant at the time of study

          -  Subject must provide written informed consent

        Exclusion Criteria:

          -  Unable or unwilling to cooperate with study procedures

          -  Currently enrolled in another clinical study for which the follow-up period is not
             complete
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randall A Hawkins, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily Verdin</last_name>
    <phone>415-353-9437</phone>
    <email>emily.verdin@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Radiology and Biomedical Imaging, UCSF</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Verdin</last_name>
      <phone>415-353-9437</phone>
      <email>emily.verdin@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Randall A Hawkins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 31, 2013</lastchanged_date>
  <firstreceived_date>December 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>low frequency ultrasound</keyword>
  <keyword>glomerular filtration rate</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
